Lesinurad Provides Additional Lowering of SUA in Gout

Article Figures & Data

Figures

  • Figure 1.

    Percentage of Patients Achieving Serum Uric Acid < 6.0 mg/dL at Month 6a

    Relative risks are post hoc calculations, not adjusted for randomization stratification factors.ALLO, allopurinol; CLEAR, Combining Lesinurad With Allopurinol in Inadequate Responders; LESU, lesinurad; PBO, placebo; SUA, serum uric acid.*P < .0001 vs PBO + ALLO arm. aNonresponder imputation. If a patient drops out or there are missing data, that patient is assumed to be a nonresponder, regardless of whether they were responding to treatment at the last measurement.Reproduced with permission from KG Saag, MD.